Stimulates insulin release when blood sugar rises after a meal, resulting in better glycemic control
Preclinical evidence shows that obese mice exhibit elevated PPARG expression, with PPARG agonists worsening hepatic steatosis
Subscribe for free and join 4,200 other investors to make sure you dont miss our next briefing: A quick update on our buy recommendations before we jump in The Trade Desk: Just joined the S&P 500 and is up 18% vs 4.5% for the S&P 500 ASML Holding: ASML had an earnings beat, but is down 6% due to weak guidance AMD: Got approval to sell chips to China and is up 11% vs -0.3% for the S&P 500 As always, here is our complete tracker in one place
This shift suggests that semaglutide may soon be viewed through a broader lens than its primary metabolic indications, particularly since obesity is a recognized risk factor for chronic migraine, a condition that disproportionately affects women
If patients present with [NAION], they should be discontinued from the medicine immediately, and their whole healthcare team should be consulted.